dc.contributor.advisor | Matherly, Larry H. | |
dc.contributor.author | Bark, Kenneth S. | |
dc.date.accessioned | 2011-10-26T13:06:02Z | |
dc.date.available | 2011-10-26T13:06:02Z | |
dc.date.issued | 1999 | |
dc.identifier.uri | http://hdl.handle.net/10920/23811 | |
dc.description | vii, 24 p. | en_US |
dc.description.abstract | The reduced folate carrier (RFC) is important for cancer patients because it is
responsible for the uptake of antifolate drugs like methotrexate (MTX) which causes cell
and tumor death. It is known that defective antifolate uptake is caused by alterations in
the RFC gene, and two mutations have been found: a glutatmate to lysine substitution at
amino acid position 45 (Glu-Lys45) and an arginine to histidine substitution at amino acid
position 27 (Arg-His27). The Arg-His27 mutation causes the appearance of a restriction
site for the enzyme DraIII, and the Glu-Lys45 mutation causes the disappearance of a
BanI restriction enzyme cutting site.
The region encompassing the RFC gene of human genomic DNA of a random
population were amplified by polymerase chain reaction (PCR). These amplifications
were then subjected to restriction digests, one by DrallI and another by BanI.
A polymorphism can be defined as a difference in DNA sequence among
individuals. Genetic variations occurring in more than 1% of a population are considered
to be polymorphisms. From the 35 patients screened with the Dram digestions, an allele
frequency of 60% for the wildtype allele and 40% for the mutant allele was determined,
and therefore, the Arg-His27 mutation can be considered to be a polymorphism. The BanI
digestions for the Glu-Lys45 mutation provided inconclusive evidence. However, through
the sequencing of certain patients it was discovered that another BanI cutting site
alteration exists on the RFC gene. An amino acid substitution seems to occur in one of
the patients at position 3 in which a leucine substitutes a proline (Pro-Leu3). Because
proline is commonly known as a helix breaker, the discovery of this polymorphism may
be a lead into changes in structure and function of the RFC protein.
Via the determined polymorphism of the Arg-His27 and the discovery of other
possible polymorphisms, insight can be drawn as to why certain cancer patients respond
to and uptake MTX more successfully. | en_US |
dc.description.sponsorship | Department of Experimental and Clinical Therapeutics. Karmos Cancer Institute. Medical School. Wayne State University. Detroit, Michigan. | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_US | en_US |
dc.publisher | Kalamazoo College | en_US |
dc.relation.ispartof | Kalamazoo College Biology Senior Individualized Projects Collection | |
dc.relation.ispartofseries | Senior Individualized Projects. Biology; | |
dc.rights | U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder. | |
dc.title | Polymorphism Determination of Mutations Found in the Human Reduced Folate Carrier Gene | en_US |
dc.type | Thesis | en_US |
KCollege.Access.Contact | If you are not a current Kalamazoo College student, faculty, or staff member, email dspace@kzoo.edu to request access to this thesis. | |